Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2021 | MA-AG | $600,000 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2006 | MA-ENV | $11,600 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | pharmaceuticals | environmental violation | 2003 | MA-ENV | $15,500 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2002 | MA-ENV | $15,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | NC-ENV | $36,836 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2009 | NJ-ENV | $10,000 |
AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2018 | NY-ENV | $21,250 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2014 | NY-ENV | $45,000 |
Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | environmental violation | 2014 | NY-ENV | $7,499 |
EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2008 | OH-ENV | $30,700 |
EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2005 | OH-ENV | $32,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2020 | VA-ENV | $20,925 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2019 | VA-ENV | $17,290 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2023 | MA-ENV | $11,615 |
ADVANCED STERILIZATION PRODUCTS INC | Johnson & Johnson | pharmaceuticals | environmental violation | 2023 | NJ-ENV | $13,300 |
PFIZER INC / GROTON SITE | Pfizer | pharmaceuticals | environmental violation | 2005 | EPA | $22,500 |
MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
LILLY DEL CARIBE INC | Eli Lilly | pharmaceuticals | environmental violation | 2000 | EPA | $39,000 |
PHARMACIA & UPJOHN CARIBE | Pfizer | pharmaceuticals | environmental violation | 2001 | EPA | $27,168 |
Phibro Animal Health Corporation | Phibro Animal Health | pharmaceuticals | environmental violation | 2006 | EPA | $82,467 |
Schering Plough Products, LLC | Merck | pharmaceuticals | environmental violation | 2010 | EPA | $11,500 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | pharmaceuticals | environmental violation | 2010 | EPA | $105,000 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | EPA | $26,797 |
MERCK SHARP & DOHME CORPORATION | Merck | pharmaceuticals | environmental violation | 2012 | EPA | $69,274 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2016 | EPA | $8,400 |
EM INDUSTRIES, INC. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
UCB CHEMICAL CORPORATION | UCB | pharmaceuticals | environmental violation | 2001 | EPA | $6,824 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | pharmaceuticals | environmental violation | 2007 | EPA | $40,950 |
ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
LAFAYETTE PHARMACEUTICALS, INC. | Mallinckrodt | pharmaceuticals | environmental violation | 2001 | EPA | $17,600 |
ALPHARMA, INC. | Zoetis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
Novartis Animal Health US, Inc. | Eli Lilly | pharmaceuticals | environmental violation | 2006 | EPA | $6,500 |
Alpharma Inc. (Chicago Heights) | Zoetis | pharmaceuticals | environmental violation | 2006 | EPA | $29,737 |
Pharmacia and Upjohn Company LLC | Pfizer | pharmaceuticals | environmental violation | 2017 | EPA | $34,170 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Genentech | Roche | pharmaceuticals | environmental violation | 2023 | EPA | $158,209 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
NOVARTIS PRODUCTS | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $13,200 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
Phibrochem, Inc. | Phibro Animal Health | pharmaceuticals | export control violation | 2012 | BIS | $31,000 |
EMD Chemicals, Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2007 | BIS | $44,000 |
Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2002 | BIS | $1,760,000 |
Elan Pharmaceuticals Inc. | Perrigo | pharmaceuticals | export control violation | 2005 | BIS | $31,000 |
Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | pharmaceuticals | export control violation | 2004 | BIS | $16,200 |
Acclarent Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
Pfizer Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Sanofi-Pasteur | Sanofi | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | USAO | $3,500,000 |
Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2011 | USAO | $1,725,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
United Therapeutics Corporation | United Therapeutics | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
Allergan Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2018 | USAO | $3,500,000 |
Astellas Pharma US Inc. | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
Actavis | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Amgen and Immunex | Amgen | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |